Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team

Get up to date on how experts are integrating CDK4/6 inhibition into adjuvant treatment of early-stage breast cancer with a focused commentary, downloadable patient resource, slides, and an archived webcast from a live workshop.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC, in partnership with Breastcancer.org and Smart Patients Inc.

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation

Partners

Breastcancer.org

ProCE Banner

Smart Patients

ProCE Banner